| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/15/2007 | WO2007018508A1 Novel m3 muscarinic acetycholine receptor antagonists |
| 02/15/2007 | WO2007018502A1 Stabilized 3-hydroxyflavan compositions and methods therefor |
| 02/15/2007 | WO2007018496A1 Methods for treating substance-related disorders |
| 02/15/2007 | WO2007018469A1 Oxopyridyl quinoline amides as nk3 receptor modulators |
| 02/15/2007 | WO2007018466A1 Alkylpyridyl quinolines as nk3 receptor modulators |
| 02/15/2007 | WO2007018465A1 Amide alkyl pyridiyl quinolines as nk3 receptor modulators |
| 02/15/2007 | WO2007018461A1 Novel benzothiazolone derivatives |
| 02/15/2007 | WO2007018460A1 Therapeutic agents |
| 02/15/2007 | WO2007018459A1 Therapeutic agents |
| 02/15/2007 | WO2007018325A1 N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof |
| 02/15/2007 | WO2007018320A1 Agent for prevention of graft loss, and screening method for the agent |
| 02/15/2007 | WO2007018319A1 Pyridylphenol compound and use thereof |
| 02/15/2007 | WO2007018316A1 Prophylactic/therapeutic agent for cancer |
| 02/15/2007 | WO2007018314A2 Therapeutic agent for diabetes |
| 02/15/2007 | WO2007018281A1 Akt ACTIVATION INHIBITOR |
| 02/15/2007 | WO2007018278A1 Inhibitor for the onset and progress of liver cancer |
| 02/15/2007 | WO2007018275A1 Design of delivery medium based on rolling model |
| 02/15/2007 | WO2007018273A1 Composition for delivering diagnostic agent containing sugar-modified liposome |
| 02/15/2007 | WO2007018272A1 Sugar-modified liposome and composition for drug delivery containing the liposome |
| 02/15/2007 | WO2007018248A1 Pyridone compound |
| 02/15/2007 | WO2007018234A1 Agent for increasing urethral pressure |
| 02/15/2007 | WO2007018226A1 Prophylactic and/or therapeutic agent for corneal disorder |
| 02/15/2007 | WO2007018210A1 Adhesive patch less irritative to skin |
| 02/15/2007 | WO2007018194A1 Method for producing cercosporamide |
| 02/15/2007 | WO2007018193A1 Novel cercosporamide derivative |
| 02/15/2007 | WO2007018192A1 Orally disintegratable tablet |
| 02/15/2007 | WO2007018168A1 Acylguanidine derivative or salt thereof |
| 02/15/2007 | WO2007018147A1 Pharmaceutical titanium dioxide composite material of which pharmacological effect can be eliminated by light irradiation |
| 02/15/2007 | WO2007018137A1 Multikinase inhibitor |
| 02/15/2007 | WO2007018124A1 Agent for enhancing collagen production and utilization of the same |
| 02/15/2007 | WO2007018057A1 Tablet rapidly disintegrating in the oral cavity and method of producing the same |
| 02/15/2007 | WO2007017914A2 Dermonecrotizing protein factors of bacterial origin and related uses in medical field |
| 02/15/2007 | WO2007017905A1 Oral pharmaceutical suspension compositions of fexofenadine |
| 02/15/2007 | WO2007017752A1 Substituted triazole derivatives as oxytocin antagonists |
| 02/15/2007 | WO2007017750A1 Benzoate salt of 4-(5-methyl-oxazolo[4,5-b]pyridin-2-yl)-1,4-diaza-bicyclo[3.2.2]nonane |
| 02/15/2007 | WO2007017740A1 Salts and polymorphs of a vergf-r inhibitor |
| 02/15/2007 | WO2007017713A1 The substance having antioxidant, geroprotective and anti-ischemic activity and method for preparing thereof |
| 02/15/2007 | WO2007017705A1 Process for the preparation of azetidinones |
| 02/15/2007 | WO2007017678A1 Pyrazolo[1,5-a] pyrimidine compounds and pharmaceutical compositions containing them |
| 02/15/2007 | WO2007017670A1 Bicyclo[2.2.]hept-7-ylamine derivatives and their uses |
| 02/15/2007 | WO2007017669A1 Azole and thiazole derivatives and their use |
| 02/15/2007 | WO2007017654A1 3, hb cis dihydrotetrabanezine for the treatment of schizophrenia and other psychoses |
| 02/15/2007 | WO2007017649A1 Heteroarylcarbamoylbenzene derivatives for the treatment of diabetes |
| 02/15/2007 | WO2007017646A2 Anti-malarial composition comprising artesunate and lumefantrine |
| 02/15/2007 | WO2007017643A1 3 , llB-CIS-DIHYDROTETRABENAZINE FOR THE TREATMENT OF A PROLIFERATIVE DISEASE OR AN INFLAMMATION |
| 02/15/2007 | WO2007017584A1 Novel camptothecin analogues compounds, a method for the preparation thereof and pharmaceutical compositions containing said compounds |
| 02/15/2007 | WO2007017577A1 7-substituted aza-indazoles, compositions containing same, production method and use thereof |
| 02/15/2007 | WO2007017539A1 Novel solid carotenoid formulations and production method thereof |
| 02/15/2007 | WO2007017514A1 Microparticle compositions of the topoisomerase i inhibitor 7-tert-butoxyiminomethylcamptothecin |
| 02/15/2007 | WO2007017512A1 Treatment of inflammatory diseases |
| 02/15/2007 | WO2007017509A1 Compounds for the treatment of alzheimer's disease |
| 02/15/2007 | WO2007017507A1 Beta-secretase inhibitors for use in the treatment of alzheimer's disease |
| 02/15/2007 | WO2007017505A2 Treatment of metabolic diseases |
| 02/15/2007 | WO2007017469A2 Process for preparing an angiotensin ii receptor antagonist |
| 02/15/2007 | WO2007017438A1 Use of tiotropium salts in the treatment of severe persistant asthma |
| 02/15/2007 | WO2007017437A1 Method for the treatment of dyspnea comprising combined administration of tiotropium salts and salts of salmeterol |
| 02/15/2007 | WO2007017436A2 Method for the protection against the risk of cardiac disorders comprising administration of tiotropium salts |
| 02/15/2007 | WO2007017265A1 Xanthine derivatives as selective hm74a agonists |
| 02/15/2007 | WO2007017262A1 Xanthine derivatives as selective hm74a agonists |
| 02/15/2007 | WO2007017261A1 Xanthine derivatives as selective hm74a agonists |
| 02/15/2007 | WO2007017253A1 Oral preparation with controlled release of a benzenesulphonamide |
| 02/15/2007 | WO2007017237A1 Imidazopyridine derivatives as cannabinoid receptor ligands |
| 02/15/2007 | WO2007017222A1 Pyrazole derivatives, their manufacture and their use as pharmaceutical agents |
| 02/15/2007 | WO2007017219A2 Pharmaceutical form with sustained ph-independent active ingredient release for active ingredients having strong ph-dependent solubility |
| 02/15/2007 | WO2007017176A1 Wound-healing composition |
| 02/15/2007 | WO2007017169A1 Phenylpyridine derivatives, their manufacture and use as pharmaceutical agents |
| 02/15/2007 | WO2007017146A2 Use of collismycin and derivatives thereof as oxidative stress inhibitors |
| 02/15/2007 | WO2007017145A2 Gsk-3 inhibitors |
| 02/15/2007 | WO2007017143A1 Azabenzimidazole derivatives, their manufacture and use as anti-cancer agents |
| 02/15/2007 | WO2007017127A2 Controlled realease dosage form of pirazole compounds to treat urinary incontinence |
| 02/15/2007 | WO2007017125A1 Cb1 antagonists or inverse antagonists as therapeutical agents for the treatment of inflammation involving gene expression |
| 02/15/2007 | WO2007017124A1 Amorphous phase of a substituted pyrazoline, its preparation and use as medicament |
| 02/15/2007 | WO2007017114A1 New substituted azathymidine derivatives and their use in the treatment of bacterial infectious diseases |
| 02/15/2007 | WO2007017096A1 Pyrazine derivatives useful as adenosine receptor antagonists |
| 02/15/2007 | WO2007017095A1 A process for the preparation of substituted phenyl ether compounds and rosiglitazone |
| 02/15/2007 | WO2007017094A1 Substituted benzyloxy-phenylmethylcarbamate derivatives |
| 02/15/2007 | WO2007017093A1 Substituted 2-benzyloxy-benzoic acid amide derivatives |
| 02/15/2007 | WO2007017092A1 Substituted 4-benzyloxy-benzoic acid amide derivatives |
| 02/15/2007 | WO2007017088A1 Amidonitrile compounds |
| 02/15/2007 | WO2007017087A1 Process for the preparation of crystalline perindopril |
| 02/15/2007 | WO2007017083A1 Pyrazole derivatives having tyrosinkinase activity |
| 02/15/2007 | WO2007017078A1 NEW PYRIDO[3',2':4,5]FURO[3,2-d]PYRIMIDINE DERIVATIVES |
| 02/15/2007 | WO2007017069A1 Adenine derivatives |
| 02/15/2007 | WO2007017058A1 Therapeutic combination comprising a nmda receptors blocker and a narcotic analgesic substance |
| 02/15/2007 | WO2007016982A1 A crystalline form of the zoledronic acid, a process to obtain it and the pharmaceutical composition comprising it |
| 02/15/2007 | WO2007016979A2 NOVEL HETEROCYCLIC NF-κB INHIBITORS |
| 02/15/2007 | WO2007016864A1 Use of fructus schisandrae and extracts thereof in preventing and decreasing toxic and side effects of antineoplastic drugs |
| 02/15/2007 | WO2007016793A1 Galantamine as a neuroprotective drug for retinal ganglion cells |
| 02/15/2007 | WO2007016784A1 Novel substituted 1,2,3-tπazolylmethyl-benzothiophene or -indole and their use as leukotπene biosynthesis inhibitors |
| 02/15/2007 | WO2007016777A1 Targeted protein kinase c inhibitors and uses thereof |
| 02/15/2007 | WO2007016771A1 Dosing regimen for weight loss |
| 02/15/2007 | WO2007016766A1 Transdermal drug delivery formulation |
| 02/15/2007 | WO2007016762A1 Perylenequinone derivatives and uses thereof |
| 02/15/2007 | WO2007016757A1 Stabilized extended release pharmeceutical compositions comprising an hmg-coa reductase inhibitor |
| 02/15/2007 | WO2007002410A3 Core-modified terpene trilactones from ginkgo biloba extract and biological evaluation thereof |
| 02/15/2007 | WO2007002174A3 A method of treatment of hormone depletion induced vasomotor symptoms |
| 02/15/2007 | WO2006136837A3 Pharmaceutical combinations comprising pyrazole derivatives as protein kinase modulators |
| 02/15/2007 | WO2006136829A3 Pyrazole derivatives and their use as pka and pkb modulators |
| 02/15/2007 | WO2006135693A3 Direct compression formulation of dpp-iv inhibitors and glitazones, and process |
| 02/15/2007 | WO2006135649A3 Aminoquinoline and aminoquinazoline kinase modulators |